Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trialZefei Jiang, Yuan Sheng, Quchang Ouyang et al.|Nature Medicine|2024Cited by 121
Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trialFei Ma, Binghe Xu, Jincai Zhong et al.|BMJ|2023Cited by 82
Safety and Current Status of the COVID-19 Vaccine among Patients with Breast cancer: A Cross-Sectional Study from ChinaShaohua Zhang, Zefei Jiang, Jianbin Li et al.|Infectious Diseases & Immunity|2023Cited by 1
Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in ChinaShaohua Zhang, Zefei Jiang, Jianbin Li et al.|JMIR Public Health and Surveillance|2023Cited by 1
Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in China (Preprint)Shaohua Zhang, Zefei Jiang, Ruonan Xu et al.|Unknown|2023Cited by 0